Myriad Genetics | MYGN - Despesa De Juros Sobre A Dívida

Preço das Ações
4.78
Mudança Diária
-0.01 -0.21%
Mensal
2.14%
Anual
-35.58%
Q2 Previsão
4.68




Despesa De Juros Sobre A Dívida Alterar Data
Agilent USD 25M 2M 2025-12
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Bruker USD 20M 4.3M 2025-09
Danaher USD 63M 8M 2026-03
Illumina USD 25M 0 2025-09
J&J USD 43M 25M 2026-03
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.68B 5.63B 2025-09
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Veracyte USD 2K 1000 2023-12
Waters USD 8.62M 18.02M 2025-12